Latest News about OCUL
Recent news which mentions OCUL
From Benzinga
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
From Benzinga
From Benzinga
From Benzinga
Tickers
OCUL
From InvestorPlace
From Benzinga
From Benzinga
2 Small-Cap Growth Stocks With Room To Run
April 24, 2024
From Motley Fool
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 19, 2024
From Benzinga
From Benzinga
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 18, 2024
From Benzinga
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
April 16, 2024
From InvestorPlace
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
April 15, 2024
From InvestorPlace
From InvestorPlace
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
From Benzinga
From Benzinga
Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
March 12, 2024
From Benzinga
ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
March 12, 2024
From Benzinga
From Benzinga
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
March 11, 2024
From Benzinga
Earnings Scheduled For March 11, 2024
March 11, 2024
From Benzinga
From Benzinga
Piper Sandler Maintains Overweight Rating for Ocular Therapeutix: Here's What You Need To Know
February 26, 2024
Tickers
OCUL
From Benzinga
3 Stocks to Buy That Are Up 100% or More in 2024
February 25, 2024
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.